Riskpilot← Back to searchSign inGet full accessMEDIEKUSKEN ApS
APSActiveCVR 35483942Hyldegårds Tværvej 10A, 2. tvWeb search portal activities · NACE 6391Est. 20131 employees
Revenue 2025
DKK 65K
-62% vs 2024
EBITDA margin
56.9%
-45% vs 2024
Equity ratio
16.3%
Financial strength
Net profit 2025
DKK 6K
-90% vs 2024
| Revenue | DKK 65K | -62% |
| EBITDA | DKK 37K | -45% |
| Net profit | DKK 6K | -90% |
| Total assets | DKK 46K | -38% |
| Equity | DKK 7K | +420% |
| Employees | 1 | — |
Legal name
MEDIEKUSKEN ApS
CVR number
35483942
Legal form
Anpartsselskab
NACE code
6391 · Web search portal activities
Founded
27. september 2013
Share capital
DKK 80.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-09-30
Financial year
January – December
Signatory rights
Selskabet tegnes af et medlem af direktionen
Company purpose
Selskabets formål er at drive virksomhed inden for medie- og kommunikationsbranchen
Address
Hyldegårds Tværvej 10A, 2. tv
Phone
+4525893032
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 362 | 254 | 397 | 223 | 264 | 236 | 195 | 175 | 25 | 67 | 169 | 65 |
| Staff expenses | -287 | -157 | -296 | -231 | -244 | -199 | -165 | -218 | -104 | -44 | -103 | -28 |
| EBITDA | -51 | -35 | -11 | -8 | 20 | 37 | 30 | -43 | -79 | 23 | 67 | 37 |
| Depreciation & amort. | -0 | -5 | -5 | -5 | -5 | -5 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -51 | -40 | -16 | -13 | 15 | 32 | 30 | -43 | -79 | 23 | 67 | 37 |
| Net financials | -0 | 1 | -0 | -0 | -0 | -0 | -1 | -0 | -1 | -3 | -1 | -1 |
| Profit before tax | -51 | -39 | -16 | -14 | 15 | 32 | 29 | -43 | -80 | 20 | 66 | 36 |
| Tax | -0 | -0 | -0 | -0 | -0 | -0 | 6 | 8 | -0 | -22 | 5 | 30 |
| Net profit | -51 | -39 | -16 | -14 | 15 | 32 | 23 | -51 | -80 | 42 | 61 | 6 |
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 77 | 52 | 41 | 55 | 60 | 64 | 54 | 49 | 84 | 114 | 74 | 46 |
| Equity | 29 | -10 | -27 | -41 | -26 | 6 | 29 | -22 | -102 | -59 | 1 | 7 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 48 | 62 | 68 | 95 | 86 | 58 | 25 | 71 | 186 | 174 | 73 | 38 |
| Total debt | 48 | 62 | 68 | 95 | 86 | 58 | 25 | 71 | 186 | 174 | 73 | 38 |
EBITDA margin
56.9%
This company
15.8%
Market median
+260% vs market
20142025
Equity ratio
16.3%
This company
38.2%
Market median
-57% vs market
20142025
Return on equity
80.8%
This company
18.4%
Market median
+339% vs market
20142025
Net profit margin
9.3%
This company
8.1%
Market median
+15% vs market
20142025
Asset turnover
1.42×
This company
1.12×
Market median
+27% vs market
20142025
Debt / equity
5.14×
This company
0.62×
Market median
-729% vs market
20142025
- Annual report 2025Filed via CVR / Virk · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via CVR / Virk · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via CVR / Virk · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via CVR / Virk · Period 2020-10-01 – 2021-09-30
- Annual report 2020Filed via CVR / Virk · Period 2019-10-01 – 2020-09-30
- Annual report 2019Filed via CVR / Virk · Period 2018-10-01 – 2019-09-30
- Annual report 2018Filed via CVR / Virk · Period 2017-10-01 – 2018-09-30
- Annual report 2017Filed via CVR / Virk · Period 2016-10-01 – 2017-09-30
- Annual report 2016Filed via CVR / Virk · Period 2015-10-01 – 2016-09-30
- Annual report 2015Filed via CVR / Virk · Period 2014-10-01 – 2015-09-30
- Annual report 2014Filed via CVR / Virk · Period 2013-09-27 – 2014-09-30
No data on file.
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 50.0% | 50.0% | 2013 | |
| Individual | 50.0% | 50.0% | 2013 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MEDIEKUSKEN ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|